» Articles » PMID: 18216518

A Heterotopic Primate Model for Facial Composite Tissue Transplantation

Overview
Journal Ann Plast Surg
Specialty General Surgery
Date 2008 Jan 25
PMID 18216518
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to develop a nonhuman primate model for heterotopic composite tissue facial transplantation in which to study the natural history of facial transplantation and evaluate immunosuppressive regimens.A composite oromandibular facial segment transplant based on the common carotid artery was evaluated. Flaps from 7 cynomolgus monkeys were transplanted to the groins of 7 recipients at the superficial femoral artery and vein. The immunosuppressive regimen consisted of thymoglobulin, rapamycin, and tacrolimus. Allograft survival ranged from 6 to 129 days. Histology performed in the long-term survivor at the time of necropsy revealed extensive inflammation and necrosis of the allograft skin; however, muscle and bone elements were viable, with minimal inflammation. This heterotopic facial transplantation model avoids the potential morbidity of mandibular resection and orthotopic facial transplantation. Our work also concurs with the work of other groups who found that the skin component is the most antigenic.

Citing Articles

Large Animal Models of Vascularized Composite Allotransplantation: A Review of Immune Strategies to Improve Allograft Outcomes.

Matar A, Crepeau R, Mundinger G, Cetrulo Jr C, Torabi R Front Immunol. 2021; 12:664577.

PMID: 34276656 PMC: 8278218. DOI: 10.3389/fimmu.2021.664577.


Preclinical Animal Models in Facial Transplantation.

Ramly E, Kantar R, Alfonso A, Diaz-Siso J, Rodriguez E Plast Reconstr Surg Glob Open. 2020; 7(9):e2455.

PMID: 31942408 PMC: 6908387. DOI: 10.1097/GOX.0000000000002455.


Primate models in organ transplantation.

Anderson D, Kirk A Cold Spring Harb Perspect Med. 2013; 3(9):a015503.

PMID: 24003248 PMC: 3753726. DOI: 10.1101/cshperspect.a015503.


Vascularized composite tissue allotransplantation--state of the art.

Diaz-Siso J, Bueno E, Sisk G, Marty F, Pomahac B, Tullius S Clin Transplant. 2013; 27(3):330-7.

PMID: 23581799 PMC: 3724233. DOI: 10.1111/ctr.12117.


Chimerism-based experimental models for tolerance induction in vascularized composite allografts: Cleveland clinic research experience.

Siemionow M, Klimczak A Clin Dev Immunol. 2013; 2013:831410.

PMID: 23573114 PMC: 3612438. DOI: 10.1155/2013/831410.